These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 14642080

  • 1. [Analysis of anti-proliferation of curcumin on human breast cancer cells and its mechanism].
    Di GH, Li HC, Shen ZZ, Shao ZM.
    Zhonghua Yi Xue Za Zhi; 2003 Oct 25; 83(20):1764-8. PubMed ID: 14642080
    [Abstract] [Full Text] [Related]

  • 2. Curcumin exerts multiple suppressive effects on human breast carcinoma cells.
    Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M.
    Int J Cancer; 2002 Mar 10; 98(2):234-40. PubMed ID: 11857414
    [Abstract] [Full Text] [Related]

  • 3. Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines.
    Shao ZM, Shen ZZ, Fontana JA, Barsky SH.
    Anticancer Res; 2000 Mar 10; 20(4):2409-16. PubMed ID: 10953303
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 5. Effect of a carotene concentrate on the growth of human breast cancer cells and pS2 gene expression.
    Nesaretnam K, Jin Lim E, Reimann K, Lai LC.
    Toxicology; 2000 Oct 26; 151(1-3):117-26. PubMed ID: 11074306
    [Abstract] [Full Text] [Related]

  • 6. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
    Liu Q, Loo WT, Sze SC, Tong Y.
    Phytomedicine; 2009 Oct 26; 16(10):916-22. PubMed ID: 19524420
    [Abstract] [Full Text] [Related]

  • 7. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].
    Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Lu LJ, Liu G, Shen ZZ, Ding J, Shao ZM.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul 26; 27(7):389-92. PubMed ID: 16188119
    [Abstract] [Full Text] [Related]

  • 8. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y, Wang SM, Huang RP.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 01; 85(20):1419-23. PubMed ID: 16029657
    [Abstract] [Full Text] [Related]

  • 9. Genistein exerts multiple suppressive effects on human breast carcinoma cells.
    Shao ZM, Wu J, Shen ZZ, Barsky SH.
    Cancer Res; 1998 Nov 01; 58(21):4851-7. PubMed ID: 9809990
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells.
    Jain PT, Rajah TT, Pento JT.
    Anticancer Drugs; 1997 Nov 01; 8(10):964-73. PubMed ID: 9436640
    [Abstract] [Full Text] [Related]

  • 11. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 01; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 12. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, Bigsby RM.
    Cancer Res; 1996 Dec 01; 56(23):5403-9. PubMed ID: 8968093
    [Abstract] [Full Text] [Related]

  • 13. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ, Saeki T, Gottardis M, Kim N, Garcia-Morales P, Martin MB, Normanno N, Ciardiello F, Day A, Cutler ML.
    J Cell Physiol; 1993 Sep 01; 156(3):497-514. PubMed ID: 8360257
    [Abstract] [Full Text] [Related]

  • 14. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
    Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3478-84. PubMed ID: 16740773
    [Abstract] [Full Text] [Related]

  • 15. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA, Sager R.
    Mol Endocrinol; 1991 Nov 01; 5(11):1613-23. PubMed ID: 1664044
    [Abstract] [Full Text] [Related]

  • 16. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 17. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ, Zhu BT.
    J Steroid Biochem Mol Biol; 2004 Mar 15; 88(3):265-75. PubMed ID: 15120420
    [Abstract] [Full Text] [Related]

  • 18. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
    Liu J, Li J, Sidell N.
    Cancer Chemother Pharmacol; 2007 Feb 15; 59(2):217-25. PubMed ID: 16738884
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray.
    Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D.
    Breast Cancer Res Treat; 2003 Jul 15; 80(1):49-62. PubMed ID: 12889598
    [Abstract] [Full Text] [Related]

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.